Search

You searched for "pathology"

1262 results found

Headaches in ophthalmology (part 2)

1 December 2018 | | EYE - Neuro-ophthalmology, EYE - General
Ophthalmologists see a large number of patients with headaches or facial pain in the ophthalmic outpatient clinics or in emergency clinics. Over two articles, I will discuss several causes of headaches, ocular manifestations and proposed management and referral options. It...

Acetylcholine receptor antibodies in the diagnosis of ocular myasthenia gravis at the Manchester Royal Eye Hospital

3 August 2023 | | EYE - Neuro-ophthalmology
Myasthenia gravis (MG) is the commonest autoimmune condition to affect the neuromuscular junction. In the UK, its prevalence is 15 per 10,000 [1,2] and recent studies have shown that rates are steadily increasing [3,4]. Aims of this audit The aim...

Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?

1 December 2022 | | EYE - General
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...

Strabismus and ocular motility, demystified

3 April 2024 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
I am a former orthoptist, now trained in medicine and working as a foundation doctor. In my previous work, I was frequently approached by ophthalmology trainees eager for guidance with strabismus and ocular motility. Drawing on my clinical experience, I...

My message to future ophthalmology teaching fellows: Organising an effective ophthalmology placement

2 October 2025 | | EYE - General
Globally, teaching ophthalmology during the undergraduate period presents challenges. The time allocated for it is minimal with substandard exposure [1,2]. Additionally, the number of universities mandating formal ophthalmology education has significantly declined [3]. Research supports the observation that doctors in...

Identifying life-threatening uveal melanoma: A directed application of general-purpose AI

2 April 2025 | | EYE - Imaging, EYE - Oncology
Uveal melanoma (UM) is a rare but aggressive eye cancer, affecting approximately six people per million annually [1]. Uveal melanoma arises in three locations: the choroid, ciliary body, and iris. As the most common primary intraocular malignancy in adults, UM...

A trip up north: Eye News Symposium 2020

24 February 2020
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Two centuries later, braille is still as important as ever, says teenage sight loss campaigner

4 January 2024 | RNIB, Braille, anniversary, campaign, blindness, Scotland, charity
Braille, the system of raised dots that has enabled blind people to read and write, is as vital as ever, and has adapted to the advances of new technology, says RNIB, Scotland's leading sight loss charity.

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

1 February 2024 | ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...

£1 million gift towards world-leading new centre for advancing eye health to enhance education

22 November 2024 | nhs, research, new hospital, London, UK, Schroder Foundation, UCL, Moorfields, developement
The Schroder Foundation and Family have donated £1 million to Moorfields Eye Charity towards the new centre for advancing eye health. The building is under construction and opening in 2027. Oriel is a joint initiative between Moorfields Eye Hospital NHS...

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

9 May 2025 | AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...